TY - JOUR
T1 - Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
AU - Maas, Renee G. C.
AU - Lee, Soah
AU - Harakalova, Magdalena
AU - Snijders Blok, Christian J. B.
AU - Goodyer, William R.
AU - Hjortnaes, Jesper
AU - Doevendans, Pieter A. F. M.
AU - van Laake, Linda W.
AU - van der Velden, Jolanda
AU - Asselbergs, Folkert W.
AU - Wu, Joseph C.
AU - Sluijter, Joost P. G.
AU - Wu, Sean M.
AU - Buikema, Jan W.
PY - 2021/3/19
Y1 - 2021/3/19
N2 - Since the discovery of human induced pluripotent stem cells (hiPSCs), numerous strategies have been established to efficiently derive cardiomyocytes from hiPSCs (hiPSC-CMs). Here, we describe a cost-effective strategy for the subsequent massive expansion (>250-fold) of high-purity hiPSC-CMs relying on two aspects: removal of cell-cell contacts and small-molecule inhibition with CHIR99021. The protocol maintains CM functionality, allows cryopreservation, and the cells can be used in downstream assays such as disease modeling, drug and toxicity screening, and cell therapy. For complete details on the use and execution of this protocol, please refer to Buikema (2020).
AB - Since the discovery of human induced pluripotent stem cells (hiPSCs), numerous strategies have been established to efficiently derive cardiomyocytes from hiPSCs (hiPSC-CMs). Here, we describe a cost-effective strategy for the subsequent massive expansion (>250-fold) of high-purity hiPSC-CMs relying on two aspects: removal of cell-cell contacts and small-molecule inhibition with CHIR99021. The protocol maintains CM functionality, allows cryopreservation, and the cells can be used in downstream assays such as disease modeling, drug and toxicity screening, and cell therapy. For complete details on the use and execution of this protocol, please refer to Buikema (2020).
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118528761&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33615277
U2 - https://doi.org/10.1016/j.xpro.2021.100334
DO - https://doi.org/10.1016/j.xpro.2021.100334
M3 - Article
C2 - 33615277
SN - 2666-1667
VL - 2
JO - STAR Protocols
JF - STAR Protocols
IS - 1
M1 - 100334
ER -